Ethics as if Your Life Depended on It

Area of Science:

• Medical Ethics
• Clinical Research Oversight
• Patient Safety

Background:

• Current ethics approval systems for medical research are based on the Belmont Report's principles.
• These systems may paradoxically delay patient access to experimental therapies, leading to preventable deaths.

Purpose of the Study:

• To examine if current ethics approval systems cause preventable deaths by delaying patient access to experimental therapies.
• To propose a framework for democratizing ethics oversight while maintaining safety.

Main Methods:

• Review of peer-reviewed evidence on ethics delays and mortality costs.
• Bayesian decision analysis to evaluate statistical thresholds for fatal diseases.
• Analysis of COVID-19 pandemic responses for insights into regulatory timeline compression.

Main Results:

• Ethics delays impose mortality costs that significantly exceed the harms they prevent, especially for terminal illnesses.
• Current statistical thresholds for research are overly conservative for fatal diseases.
• The COVID-19 pandemic demonstrated that regulatory timelines can be compressed without compromising safety.

Conclusions:

• A five-part framework can enhance patient autonomy in research ethics.
• The framework includes tiered consent, adaptive trial designs with patient governance, open-source transparency, post-market surveillance, and independent safety monitoring with patient representation.
• This approach preserves robust safeguards against exploitation while enabling patient autonomy.